|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| C07K 14/705 | |||
| C12N 5/10 | |||
| C07K 16/22 |
| (11) | Number of the document | 3269381 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17175570.5 |
| Date of filing the European patent application | 2006-11-22 | |
| (97) | Date of publication of the European application | 2018-01-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 739462 P | 2005-11-23 | US | |
| 783322 P | 2006-03-17 | US | |
| 844855 P | 2006-09-15 | US |
| (72) |
KNOPF, John, US
JASBIR, Seehra, US
|
| (73) |
Acceleron Pharma, Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTIVIN-ACTRIIA ANTAGONISTS IN USE FOR PROMOTING BONE GROWTH |
| ACTIVIN-ACTRIIA ANTAGONISTS IN USE FOR PROMOTING BONE GROWTH |